Literature DB >> 21551949

Plasma miR-124 as a biomarker for cerebral infarction.

Huachun Weng1, Chunshen Shen, Gou Hirokawa, Xu Ji, Rie Takahashi, Kana Shimada, Chiharu Kishimoto, Naoharu Iwai.   

Abstract

MicroRNAs (miRNAs) are endogenous small RNAs that play an important role in various physiological processes by downregulating target genes. Recently, plasma miRNAs have been investigated as biomarkers for various diseases. In this study, miRNA array analysis in various tissues showed that miR-124 is almost exclusively expressed in the central nervous system and neuronal cells, suggesting that it might be useful as a potential biomarker for neurological diseases. We examined whether plasma concentrations of brain-specific miRNA can serve as a biomarker for cerebral infarction, where the cerebral infarction was modeled by middle cerebral artery occlusion (MCAO) in the rat. Plasma concentrations of miR-124 were significantly elevated at 6 h, and remained elevated at 48 h after MCAO introduction. Thus, plasma concentration of miR-124 provides a promising candidate biomarker for early detection of cerebral infarction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21551949     DOI: 10.2220/biomedres.32.135

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  42 in total

Review 1.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

Review 2.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

Review 3.  The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine.

Authors:  Alireza Majdi; Javad Mahmoudi; Saeed Sadigh-Eteghad; Mehdi Farhoudi; Siamak Sandoghchian Shotorbani
Journal:  Neurol Sci       Date:  2016-06-27       Impact factor: 3.307

Review 4.  Angiogenesis-regulating microRNAs and Ischemic Stroke.

Authors:  Ke-Jie Yin; Milton Hamblin; Y Eugene Chen
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

5.  miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion.

Authors:  Xiaowen Zhang; Xiongweiye Huang; Chen Fang; Qian Li; Jing Cui; Jing Sun; Liang Li
Journal:  Mol Neurobiol       Date:  2016-03-16       Impact factor: 5.590

Review 6.  Non-coding RNAs and neuroprotection after acute CNS injuries.

Authors:  Raghavendar Chandran; Suresh L Mehta; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2017-01-26       Impact factor: 3.921

7.  Effects of acupuncture at Baihui (GV 20) and Zusanli (ST 36) on peripheral serum expression of MicroRNA 124, laminin and integrin β1 in rats with cerebral ischemia reperfusion injury.

Authors:  Su-Hui Chen; Hua Sun; Ya-Min Zhang; Hong Xu; Yang Yang; Fu-Ming Wang
Journal:  Chin J Integr Med       Date:  2015-10-01       Impact factor: 1.978

8.  miR-124-3p is a chronic regulator of gene expression after brain injury.

Authors:  Niina Vuokila; Katarzyna Lukasiuk; Anna Maria Bot; Erwin A van Vliet; Eleonora Aronica; Asla Pitkänen; Noora Puhakka
Journal:  Cell Mol Life Sci       Date:  2018-08-28       Impact factor: 9.261

9.  Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy.

Authors:  Jing Peng; Ahmed Omran; Muhammad Usman Ashhab; Huimin Kong; Na Gan; Fang He; Fei Yin
Journal:  J Mol Neurosci       Date:  2013-01-15       Impact factor: 3.444

10.  Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways.

Authors:  Thorsten R Doeppner; Britta Kaltwasser; Eduardo H Sanchez-Mendoza; Ahmet B Caglayan; Mathias Bähr; Dirk M Hermann
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.